Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | GPR119 | Q8TDV5 | 11/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.38 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16973168 | 0.79 | ALDH1A1 (0.51) | MAPTALDH1A1LMNAGPR119 | |
| SCHEMBL15322640 | 0.79 | ALDH1A1 (0.44) | MAPTALDH1A1LMNA | |
| SCHEMBL10035920 | 0.78 | ALDH1A1 (0.56) | MAPTALDH1A1LMNAGPR119THRB | |
| SCHEMBL31216608 | 0.78 | GPR119 (0.64) | MAPTALDH1A1LMNAGPR119 | |
| SCHEMBL2255441 | 0.78 | GPR119 (0.64) | MAPTALDH1A1LMNAGPR119 | |
| SCHEMBL31216598 | 0.78 | GPR119 (0.64) | MAPTALDH1A1LMNAGPR119 | |
| SCHEMBL29554755 | 0.78 | ALDH1A1 (0.56) | MAPTALDH1A1LMNAGPR119THRB | |
| SCHEMBL31043946 | 0.78 | LMNA (0.52) | MAPTALDH1A1LMNAGPR119DPP4 | |
| SCHEMBL23783010 | 0.77 | MAPT (0.54) | MAPTALDH1A1LMNAGPR119DPP4 | |
| SCHEMBL23783425 | 0.77 | PTPN2 (0.54) | MAPTALDH1A1LMNAPTPN2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059577-A1 | SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS | ATAVISTIK BIO, INC. (US) | 2025-03-20 | — | — | WO | disclosed |